Historical record - last NADAC effective date: 7/1/2024
Product Information
TIROSINT 200 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.4729 per EA under NDC 71858006004. Its NADAC has been published 251 times since Dec 18, 2019.
FDA first approved this application on Oct 13, 2006.
The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 ug/1
Manufacturer
IBSA Pharma Inc.NDC
71858006004
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021924FDA Approved
10/13/2006
On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT 200 MCG CAPSULE has been published 251 times since Dec 18, 2019, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4729 per EA |
|---|---|
| All-time high | $4.4729 (Oct 2, 2024) |
| All-time low | $4.1262 (Dec 18, 2019) |
| Median price | $4.2553 |
| Average price | $4.2926 |
| Largest weekly change | +4.0% (Dec 25, 2019) |
| Weeks tracked | 251 |
| Tracking since | Dec 18, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+1.4%
5Y
+5.2%
All
+8.4%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIROSINT 200 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 200 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.4729 per EA (NDC 71858006004), effective Oct 2, 2024.
How has the price of TIROSINT 200 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIROSINT 200 MCG CAPSULE has risen 8.4%. It has been tracked across 251 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for TIROSINT 200 MCG CAPSULE?
Since Dec 18, 2019, the NADAC for TIROSINT 200 MCG CAPSULE has ranged from a low of $4.1262 (Dec 18, 2019) to a high of $4.4729 (Oct 2, 2024), with a median of $4.2553 per EA.
Are there cheaper alternatives to TIROSINT 200 MCG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOTHYROXINE 200 MCG CAPSULE, is $2.6046 per EA — about 42% below TIROSINT 200 MCG CAPSULE.
Who manufactures TIROSINT 200 MCG CAPSULE?
TIROSINT 200 MCG CAPSULE (NDC 71858006004) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.